United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $493.10 -0.31%
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Super Micro Computer rises on AI server market optimism
- RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
